How youβll make an impact:
- Identify, establish, and maintain long-term collaborative partnerships with KOLs, investigators, healthcare providers (HCPs), and academic institutions.
- As a field-based extension of the Medical Affairs team, support high-quality execution of R&D initiatives including Phase 2b and Phase 3 clinical trials via proactive and reactive trial site engagement, education, and internal collaboration.
- Present data and conduct balanced peer-to-peer scientific exchange and education on company products and science with KOLs, HCPs, academic institutions, clinical investigators, and other stakeholders, consistent with company policies.
- Represent the company at scientific conferences and meetings to drive awareness, support medical booth activities as needed, cultivate relationships, and gather real-world insights and competitive intelligence.
- Collaborate on development and implementation of the scientific communication plan and medical-to-medical materials.
- Develop and maintain cross-functional partnerships with regulatory, commercial, and clinical development.
- Gather field insights on data, therapeutic area, and competitive intelligence to inform company strategies and evidence generation plans.
- Ensure compliance with internal and external regulatory and legal guidelines.
- Maintain clinical, scientific, and technical expertise in the therapeutic area.
Skills and experience youβll bring:
- Advanced scientific degree (PharmD, MD, PhD, PA-C, NPPA) required.
- Seasoned MSL professional in pharmaceutical or biotech.
- Strong understanding of clinical research methodologies; ability to independently evaluate and translate scientific material.
- Strong understanding of immunology therapeutic area and clinical development; Dermatology or Allergy/Immunology experience preferred.
- Excellent communication, presentation, and interpersonal skills.
- Ability to travel up to 50% (typically 35β50%).
Compensation:
- Anticipated base salary range: $195,000β$275,000; eligible for annual bonus, equity participation, and comprehensive benefits.